Annual Drug Patent Expirations for AUSTEDO+XR
Austedo Xr is a drug marketed by Teva and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
Drug patent litigation for AUSTEDO XR.
This drug has fourteen patent family members in thirteen countries.
The generic ingredient in AUSTEDO XR is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
